Determination of rosuvastatin in the presence of its degradation products by a stability-indicating LC method

Journal of AOAC International

Volumn 88, Issue 4, 2005, Pages 1142-1147

  Mehta, Tushar N ^a   Patel, Atul K ^a   Kulkarini, Gopal M ^a   Suubbaiah, Gunta ^a  

^a C/O Torrent Pharmaceutical Ltd ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DEGRADATION; IMPURITIES; LIQUID CHROMATOGRAPHY; OPTIMIZATION; OXIDATION; PH EFFECTS; PHOTOLYSIS; THERMAL STRESS;

ROSUVASTATIN CA; STABILITY-INDICATING ASSAYS; TABLET FORMULATION;

DRUG PRODUCTS;

EID: 25444511109     PISSN: 10603271     EISSN: None     Source Type: Journal    
DOI: 10.1093/jaoac/88.4.1142     Document Type: Article

References (6)

1. Lennernas, H., & Fager, G. (1997) Clin. Pharmacokinet. 32, 403-425
2. McTaggart, F., Buckette, L., Davidson, R., Holdgate, G., McCormick, A., Schneck, D., Smith, G., & Warwick, M. (2001 Am. J. Cardiol. 87, 28B-32B
3. Kivisto, K.T., Kantola, T., & Jneuvonen, P. (1998) Br. J. Clin. Pharmacol. 46, 49-53
4. Neuvonen, P.J., Kantola, T., & Kivisto, K.T. (1998) Clin. Pharmacol Ther. 63, 332-341
5. Hull, C.K., Penman, A.D., Smith, C.K., & Martin, P.D. (2002) J. Chromatogr. B 772, 219-228
6. Hull, C.K., Martin, P.D., Michael J. W., & Thomas, E. (2004) J. Pharm. Biomed. Anal. 35, 609-614